COM:SUPERNUS
Supernus Pharmaceuticals
- Stock
locale
United Statesmarket
STOCKSindustry
Pharmaceuticalswebsite
www.supernus.com/ipo date
May 01, 2012
Supernus Pharmaceuticals, Inc., a biopharmaceutical company, focuses on the development and commercialization of products for the treatment of central nervous system (CNS) diseases in the United States. Its commercial products are Trokendi XR, an extended release topiramate product indicated for the treatment of epilepsy, as well as for the prophylaxis of migraine headache; and...Show More